1. Home
  2. LADR vs WVE Comparison

LADR vs WVE Comparison

Compare LADR & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ladder Capital Corp

LADR

Ladder Capital Corp

BUY

Current Price

$9.71

Market Cap

1.3B

Sector

Real Estate

ML Signal

BUY

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$5.68

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LADR
WVE
Founded
2008
2012
Country
United States
Singapore
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
2013
2015

Fundamental Metrics

Financial Performance
Metric
LADR
WVE
Price
$9.71
$5.68
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
16
Target Price
$12.25
$29.81
AVG Volume (30 Days)
1.1M
2.3M
Earning Date
04-23-2026
04-28-2026
Dividend Yield
8.98%
N/A
EPS Growth
N/A
N/A
EPS
0.14
N/A
Revenue
N/A
$3,704,000.00
Revenue This Year
$31.66
N/A
Revenue Next Year
$16.92
$85.67
P/E Ratio
$70.07
N/A
Revenue Growth
N/A
149.43
52 Week Low
$9.43
$5.02
52 Week High
$11.92
$21.73

Technical Indicators

Market Signals
Indicator
LADR
WVE
Relative Strength Index (RSI) 47.18 45.39
Support Level N/A $5.49
Resistance Level $10.42 $6.48
Average True Range (ATR) 0.23 0.26
MACD 0.01 0.01
Stochastic Oscillator 42.70 36.47

Price Performance

Historical Comparison
LADR
WVE

About LADR Ladder Capital Corp

Ladder Capital Corp is an internally-managed real estate investment trust that is in commercial real estate finance. The company originates and invests in a diverse portfolio of commercial real estate and real estate-related assets, focusing on senior secured assets. The company's investment activities include: (i) Primary business of originating senior first mortgage fixed and floating rate loans collateralized by commercial real estate with flexible loan structures; (ii) owning and operating commercial real estate, including net leased commercial properties; and (iii) investing in investment-grade securities secured by first mortgage loans on commercial real estate. The company has three reportable segments: Loans, which derive maximum revenue; Securities; and Real Estate.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: